David J Grainger Centessa Pharmaceuticals PLC (CNTA) insider trading activity
David J Grainger is Chief Innovation Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 962,790 shares of CNTA, which is worth approximately $16.3 Million. The most recent transaction as insider was on Dec 31, 2023, when has been sold 4,700 shares (Ordinary Shares) at a price of $7.96 per share, resulting in proceeds of $37,412. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
963K
0%
3M change
0.49%
12M change
Total Value Held
$16.3 Million
DAVID J GRAINGER Transaction History
DJG
David J Grainger
Chief Innovation Officer
Cheshire, X0